
Sumatriptan succinate is a premium active pharmaceutical ingredient (API) carrying CAS number 103628-48-4. Well-regarded for its targeted serotonin receptor binding affinity and excellent white crystalline powder uniformity, this high-purity triptan salt functions as an indispensable core compound for manufacturing clinical-grade anti-migraine tablets, nasal spray solutions, and rapid subcutaneous injections globally.
Excellent water solubility profiles and stable crystalline properties offer a clear processing advantage when formulating modern vascular therapies. This active pharmaceutical solid operates by selectively stimulating specific cranial receptor channels, supplying the exact biological mechanics required to restrict localized vascular swelling without altering background binder performance. It assists plant operators in achieving flawless uniformity during large-scale dry granulation runs, mitigating segregation risks within automated tablet press hoppers. For instance, commercial manufacturing plants incorporate this triptan salt as their primary active component in rapid-dissolve tablet lines. As a consequence, it maximizes the technical throughput of high-speed packaging machinery and continuous quality screening tools. Consequently, Zyntex coordinates clean production streams to eliminate downstream crystalline shifts from your factory workflow.
In addition to this, Zyntex provides temperature-monitored distribution setups for pilot-scale trials and advanced pharmaceutical formulation research centers. The material preserves its high physical stability during mechanical milling operations, preventing heat-induced polymorph changes or chemical breakdown during fluid-bed drying steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine ultra-performance liquid chromatography (UPLC) assays and quantitative validation methods. In brief, our product serves as a dependable chemical foundation, supporting both the performance of commercial tablet batches and the analytical rigor of specialized industrial laboratories.
This high-purity crystalline therapeutic compound provides essential technical value across these four primary sectors:
Acts as the primary active drug substance for pressing uniform, fast-acting oral therapeutic tablets. Hence, it directly supports optimal dosage control lines.
Utilized as a water-soluble active base to mix rapid-absorption intranasal sprays and sterile liquid blocks. Clearly, it is key for uniform dissolving patterns.
Serves as an essential reference active standard for evaluating stability, impurity testing, and laboratory assays. Resultantly, it guarantees excellent matrix clarity.
Integrated into specialized polymer matrices to test sustained-delivery coatings and targeted drug carriers. Specifically, it confirms optimal reaction pathways.
| Parameter | Standard Value |
|---|---|
| Product Name | Sumatriptan Succinate |
| Assay / Purity (HPLC) | Min 99.0% |
| Appearance | White to off-white crystalline powder |
| Melting Point | Approx. 165 °C |
| Solubility | Soluble in water; sparingly soluble in ethanol |
| CAS Number | 103628-48-4 |
📝 Safety & Handling: Sumatriptan succinate is a biologically potent neuroactive drug compound. Inhaling airborne dust or skin contact during dispensing can trigger targeted pharmacological absorption, causing potential dizziness, temporary blood pressure changes, or mucosal irritation. Therefore, store strictly in original airtight containers within a temperature-regulated, dry warehouse away from moisture and strong light. Avoid generating dust clouds during weighing. Wearing proper personal protective equipment (PPE)—including solvent-resistant nitrile gloves, chemical safety glasses, and a certified dust respirator mask—is required during all material transfer stages. Review the Safety Data Sheet (SDS) for cleanroom ventilation guidelines.